Pulse Oximeter Market to be Worth $3.40 Billion by 2031
|
|
Meticulous
Research®, a leading market research company, has released a new report titled
"Pulse
Oximeter Market Size, Share, Forecast, & Trends Analysis by Component
(Device {Prescription, OTC}, SPO2 Sensors) Portability (Handheld, Wearable,
Fingertip) Technology (Connected, Conventional) Age (Adult, Pediatric) End
User – Global Forecast to 2031."
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5867
According to this latest study, the
global pulse oximeter market is anticipated to reach $3.40 billion by 2031,
growing at a CAGR of 5.4% from 2024 to 2031. Key factors driving this growth
include the increasing number of hospitalizations, the application of pulse
oximeters in newborn screenings, the rising prevalence of Chronic Obstructive
Pulmonary Disease (COPD) and asthma, and the expanding market for
over-the-counter (OTC) pulse oximeters. Nevertheless, concerns regarding data
accuracy and regulatory challenges surrounding OTC devices may impede market
growth. On the other hand, advancements in technology, the growing adoption of
wearable devices, and innovations in sensor technologies are expected to
create significant opportunities for market participants. However, the
emergence of mobile-based alternatives for monitoring blood oxygen levels
presents a potential challenge.
The report profiles key players in the
pulse oximeter market, including Medtronic plc (Ireland), Koninklijke Philips
N.V. (Netherlands), GE HealthCare Technologies, Inc. (U.S.), Masimo
Corporation (U.S.), Beurer GmbH (Germany), Nonin Medical, Inc. (U.S.), Nihon
Kohden Corporation (Japan), Drägerwerk AG & Co. KGaA (Germany), ICU
Medical, Inc. (U.S.), and Spacelabs Healthcare (a subsidiary of OSI Systems,
Inc.) (U.S.).
The pulse oximeter market is segmented by
Component (Devices [Prescription Pulse Oximeters, OTC Pulse Oximeters] and
Sensors [Disposable SpO2 Sensors, Reusable SpO2 Sensors]), Portability
(Handheld, Fingertip, Wearable, Bench-top), Technology (Conventional,
Connected), Age Group (Adults, Pediatrics [Fetal, Neonatal, Infant
Monitoring]), End User (Hospitals & Clinics, Home Care Settings,
Ambulatory Care Centers, Other End Users), and Geography. The study provides a
detailed evaluation of industry competitors and market dynamics at regional
and country levels.
Request Sample Report Here @ https://www.meticulousresearch.com/request-sample-report/cp_id=5867
Market Insights by Segment:
·
Component: In 2024, the devices
segment is projected to capture the largest share of the market, driven by an
aging population, the rising burden of chronic diseases, and increased use by
athletes and fitness enthusiasts. The integration of pulse oximetry in wearable
devices for continuous monitoring is also a significant growth driver.
·
Portability: Fingertip pulse
oximeters are expected to exhibit the highest CAGR during the forecast period
due to their compact size, ease of use, low power consumption, and accurate
readings. These devices facilitate early detection of low blood oxygen levels.
·
Technology: Conventional pulse
oximeters are anticipated to hold the largest market share in 2024, attributed
to their widespread use in primary healthcare and emergency settings and their
affordability.
·
Age Group: The pediatrics
segment is expected to grow at the highest CAGR, fueled by increasing
awareness of newborn screening and a rising number of companies offering
related products. Recent FDA approvals, such as Owlet Baby Care's BabySat
device, further support this growth.
·
End User: The home care
settings segment is forecasted to register the highest CAGR, driven by the
growing trend of home healthcare, an aging population, and advancements in
remote patient monitoring technologies.
Geographical Insights:
In 2024, North America is expected to
dominate the pulse oximeter market, thanks to the extensive adoption of
telehealth services, a robust healthcare infrastructure, and the presence of
major market players.
Key Players in North America:
Prominent companies operating in the
North American market include Medtronic plc (Ireland), Koninklijke Philips
N.V. (Netherlands), Masimo Corporation (U.S.), Nonin Medical, Inc. (U.S.),
Owlet Baby Care, Inc. (U.S.), ICU Medical, Inc. (U.S.), and GE HealthCare
Technologies, Inc. (U.S.).
Buy Now @ https://www.meticulousresearch.com/Checkout/37714278
About
Meticulous Research®
Meticulous Research® was founded in 2010
and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private
limited company under the Companies Act, 1956. Since its incorporation, the
company has become the leading provider of premium market intelligence in
North America, Europe, Asia-Pacific, Latin America, and the Middle East &
Africa.
The name of our company defines our
services, strengths, and values. Since the inception, we have only thrived to
research, analyze, and present the critical market data with great attention
to details. With the meticulous primary and secondary research techniques, we
have built strong capabilities in data collection, interpretation, and
analysis of data including qualitative and quantitative research with the
finest team of analysts. We design our meticulously analyzed intelligent and
value-driven syndicate market research reports, custom studies, quick
turnaround research, and consulting solutions to address business challenges
of sustainable growth.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment